2017
DOI: 10.1158/0008-5472.can-17-0835
|View full text |Cite|
|
Sign up to set email alerts
|

Integrating Models to Quantify Environment-Mediated Drug Resistance

Abstract: Drug resistance is the single most important driver of cancer treatment failure for modern targeted therapies, and the dialog between tumor and stroma has been shown to modulate the response to molecularly targeted therapies through proliferative and survival signaling. In this work, we investigate interactions between a growing tumor and its surrounding stroma and their role in facilitating the emergence of drug resistance. We used mathematical modeling as a theoretical framework to bridge between experimenta… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 48 publications
1
28
0
Order By: Relevance
“…Given we intend to use our neurogenesis model to estimate a key quantity of interest that lacks experimental quantification: the founder population, . For each species of interest, we use Approximate Bayesian Computation (ABC, see Supplemental Information and Picco et al 2017 ) to obtain an estimate of This method gives the best fit to match the neurogenic output given the model of choice (constant, or age-dependent, cell cycle length), and the corresponding strategy. Figure 5 B shows the estimates of for the 3 species and 2 models.…”
Section: Resultsmentioning
confidence: 99%
“…Given we intend to use our neurogenesis model to estimate a key quantity of interest that lacks experimental quantification: the founder population, . For each species of interest, we use Approximate Bayesian Computation (ABC, see Supplemental Information and Picco et al 2017 ) to obtain an estimate of This method gives the best fit to match the neurogenic output given the model of choice (constant, or age-dependent, cell cycle length), and the corresponding strategy. Figure 5 B shows the estimates of for the 3 species and 2 models.…”
Section: Resultsmentioning
confidence: 99%
“…This includes the modeling of bone as a reservoir of latent TGF-β that is released and activated during tumor-induced osteolysis, which in turn impacts the osteoblast:osteoclast balance in the remodeling unit. (56) In addition, the role of cancer-associated fibroblasts (57) and immune cells (58) in tumor cell metastasis has been modeled, which is of particular interest given the diverse cellular environment of the bone metastatic niche.…”
Section: Ex Vivo Bone Modelsmentioning
confidence: 99%
“…Previous mathematical models designed to study cooperative or competitive interactions between tumor and immune cells have quantified the proliferation response of the immune system to changing tumor burden [30][31][32] and response to therapy 33 . Others have used agent-based models 34 or hematoxylin and eosin-stained images 35 to show the importance of spatial organization of heterogeneous immune-evasive "hotspots" within a tumor, especially in the context of competition for shared resources (e.g.…”
Section: Ductal Carcinomas As a Case Of Changing Contextmentioning
confidence: 99%